Regeneron Pharmaceuticals on Track for Largest Percent Decrease Since June 2023 — Data Talk

Regeneron Pharmaceuticals, Inc. (REGN) is currently at $910.44, down $25.77 or 2.75%

--Would be lowest close since Jan. 10, 2024, when it closed at $906.16

--On pace for largest percent decrease since June 27, 2023, when it fell 8.71%

--Currently down three of the past four days

--Currently down two consecutive days; down 3.54% over this period

--Worst two day stretch since the two days ending Nov. 9, 2023, when it fell 3.67%

--Down 5.41% month-to-date

--Up 3.66% year-to-date

--Down 8.35% from its all-time closing high of $993.35 on Feb. 27, 2024

--Up 9.64% from 52 weeks ago (April 13, 2023), when it closed at $830.35

--Down 8.35% from its 52-week closing high of $993.35 on Feb. 27, 2024

--Up 31.48% from its 52-week closing low of $692.45 on July 7, 2023

--Traded as low as $909.80; lowest intraday level since Jan. 11, 2024, when it hit $899.07

--Down 2.82% at today's intraday low; largest intraday percent decrease since Jan. 8, 2024, when it fell as much as 3.52%

--Sixth worst performer in the S&P 500 today

--Second worst performer in the Nasdaq 100 today

All data as of 10:00:42 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

April 11, 2024 10:19 ET (14:19 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.